163
Views
13
CrossRef citations to date
0
Altmetric
Clinical Features

Comorbidity and its Impact in Adult Patients with Attention-Deficit/Hyperactivity Disorder: A Primary Care Perspective

, DO & , PhD
Pages 73-82 | Published online: 13 Mar 2015

References

  • . Kessler RC, Adler LA, Barkley R, . Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry. 2005;57(11):1442–1451
  • . Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002;111(2):279–289
  • . Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry. 2000;157(5):816–818
  • . Kessler RC, Adler L, Barkley R, . The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–723
  • . Robison LM, Skaer TL, Sclar DA. Is attention-deficit hyperactivity disorder (ADHD) diagnosed in adults? An examination of US office-based physician visits, 1995–2000. Int J Pharm Med. 2004;18(6):337–341
  • . Adler LA. Issues in the treatment and diagnosis of adult attention deficit-hyperactivity disorder (ADHD) in adults by primary care physicians. Poster presented at: the Collegium Internationale Neuro-Psychopharmacologicum; July 9–13, 2006; Chicago, IL
  • . Donnelly CL, Reimherr FW, Young JL. Differential diagnosis and treatment of adult ADHD and neighboring disorders. CNS Spectr. 2006;11(10 suppl 11):1–14
  • . Culpepper L. Primary care treatment of attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2006;67( suppl 8):51–58
  • . Adler LA, Sitt DJ, Nierenberg A. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder. Poster presented at: American Academy of Child and Adolescent Psychiatry; October 27, 2006; San Diego, CA
  • . Wilens TE, Dodson W. A clinical perspective of attention-deficit/hyperactivity disorder into adulthood. J Clin Psychiatry. 2004;65(10):1301–1313
  • . Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602
  • . Biederman J, Monuteaux MC, Mick E, . Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med. 2006;36(2):167–179
  • . Pliszka SR. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am. 2000;9(3):525–540, vii
  • . Braaten EB, Beiderman J, Monuteaux MC, . Revisiting the association between attention-deficit/hyperactivity disorder and anxiety disorders: a familial risk analysis. Biol Psychiatry. 2003;53(1):93–99
  • . Wilens TE, Biederman J, Wozniak J, Gunawardene S, Wong J, Monuteaux M. Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults. Biol Psychiatry. 2003;54(1):1–8
  • . Findling RL. Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series. J Child Adolesc Psychopharmacol. 1996;6(3):165–175
  • . Fischer AG, Bau CH, Grevet EH, . The role of comorbid major depressive disorder in the clinical presentation of adult ADHD. J Psychiatr Res. 2007;41(12):991–996
  • . Spencer TJ, Biederman J, Mick E. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. Ambul Pediatr. 2007;7( suppl 1):73–81
  • . Loeber R, Burke JD, Lahey BB. What are adolescent antecedents to antisocial personality disorder? Crim Behav Ment Health. 2002;12(1):24–36
  • . Lahey BB, Loeber R, Burke JD, Applegate B. Predicting future antisocial personality disorder in males from a clinical assessment in childhood. J Consult Clin Psychol. 2005;73(3):389–399
  • . Moffitt TE. Juvenile delinquency and attention deficit disorder: boys' developmental trajectories from age 3 to age 15. Child Dev. 1990;61(3):893–910
  • . Satterfield JH, Schell A. A prospective study of hyperactive boys with conduct problems and normal boys: adolescent and adult criminality. J Am Acad Child Adolesc Psychiatry. 1997;36(12):1726–1735
  • . Moffitt TE, Caspi A, Harrington H, Milne BJ. Males on the life-course-persistent and adolescence-limited antisocial pathways: follow-up at age 26 years. Dev Psychopathol. 2002;14(1):179–207
  • . Schubiner H, Tzelepis A, Milberger S, . Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry. 2000;61(4):244–251
  • . Hovens JG, Cantwell DP, Kiriakos R. Psychiatric comorbidity in hospitalized adolescent substance abusers. J Am Acad Child Adolesc Psychiatry. 1994;33(4):476–483
  • . Busch B, Biederman J, Cohen LG, . Correlates of ADHD among children in pediatric and psychiatric clinics. Psychiatr Serv. 2002;53(9):1103–1111
  • . Montano B. Diagnosis and treatment of ADHD in adults in primary care. J Clin Psychiatry. 2004;65( suppl 3):18–21
  • . Wasserstein J. Diagnostic issues for adolescents and adults with ADHD. J Clin Psychol. 2005;61(5):535–547
  • . American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision: DSM-IV-TR. 4th ed. Washington, DC: American Psychiatric Association; 2000
  • . Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004;27(2):187–201
  • . Adler L, Kessler R, Spencer T. Adult Self Report Scale, ASRS-V1.1 Screener. New York, NY: World Health Organization; 2003
  • . Kessler RC, Adler L, Ames M, . The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245–256
  • . Adler LA, Spencer T, Faraone SV, . Validity of pilot Adult ADHD Self- Report Scale (ASRS) to Rate Adult ADHD symptoms. Ann Clin Psychiatry. 2006;18(3):145–148
  • . Rosler M, Retz W, Thome J, Schneider M, Stieglitz RD, Falkai P. Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. 2006;256( suppl 1):i3–i11
  • . Barkley RA, Murphy KR. Attention-Deficit Hyperactivity Disorder. A Clinical Workbook. 2nd ed. New York, NY: Guilford; 1998
  • . Adler L, Spencer T, Biederman J. Adult ADHD Investigator, Symptom Rating Scale. New York, NY: New York University School of Medicine; 2003
  • . Conners CK, Erhardt D, Sparrow EP. Conners' Adult ADHD Rating Scales (CAARS) Technical Manual. North Tonawanda, NY: Multi-Health Systems Inc; 1999
  • . Wender PH. Attention-Deficit Hyperactivity Disorder in Adults. Oxford, England: Oxford University Press; 1995
  • . First MB, Spitzer RL, Gibbon M, . Structured Clinical Interview for Axis I DSM-IV Disorders-Patient Edition (With Psychotic Screen) (SCID-1/P) (Version 2.0). New York, NY: Biometrics Research, New York State Psychiatric Institute; 1996
  • . Derogatis LR. Symptom Checklist-90 (Revised): Administration, Scoring, and Procedures Manual, II. Towson, MD: Clinical Psychometric Research; 1992
  • . Spencer TJ, Faraone SV, Michelson D, . Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity. J Clin Psychiatry. 2006;67(3):415–120
  • . Spencer T, Biederman J, Wilens T, . A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005;57(5):456–463
  • . Riordan HJ, Flashman LA, Saykin AJ, Frutiger SA, Carroll KE, Huey L. Neuropsychological correlates of methylphenidate treatment in adult ADHD with and without depression. Arch Clin Neuropsychol. 1999; 14(2): 217–233
  • . Spencer T, Wilens T, Biederman J, Faraone SV, Ablon JS, Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry. 1995;52(6):434–143
  • . Wilens TE, Biederman J, Prince J, . Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry. 1996;153(9):1147–1153
  • . Jensen PS, Hinshaw SP, Kraemer HC, . ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001;40(2):147–158
  • . Pliszka SR. Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry. 1989;28(6):882–887
  • . Sobanski E. Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. 2006;256( suppl 1):i26–i31
  • . Wender PH, Reimherr FW, Wood D, Ward M. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry. 1985;142(5):547–552
  • . Horrigan JP, Barnhill LJ. Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2000;61(6):414–417
  • . Adler LA, Reingold LS, Morrill MS, Wilens TE. Combination pharmacotherapy for adult ADHD. Curr Psychiatry Rep. 2006;8(5):409–415
  • . Gammon GD, Brown TE. Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. J Child Adolesc Psychopharmacol. 1993;3:1–10
  • . Myronuk LD, Weiss M, Cotter L. Combined treatment with moclobemide and methylphenidate for comorbid major depression and adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 1996;16(6):468–469
  • . Scheffer RE, Kowatch RA, Carmody T, Rush AJ. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry. 2005;162(1):58–64
  • . Somoza EC, Winhusen TM, Bridge TP, . An open-label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder. J Addict Dis. 2004;23(1):77–92
  • . Levin FR, Evans SM, McDowell DM, Brooks DJ, Nunes E. Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder. J Addict Dis. 2002;21(2):1–16
  • . Riggs PD, Hall SK, Mikulich-Gilbertson SK, Lohman M, Kayser A. A randomized controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry. 2004;43(4):420–129
  • . Carpentier PJ, de Jong CA, Dijkstra BA, Verbrugge CA, Krabbe PF. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. Addiction. 2005;100(12):1868–1874

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.